Reference health
Resveratrol: Evidence for Its Nephroprotective Effect in Diabetic Nephropathy
95/95 checkable references clean · checked 2026-07-22
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
7 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 95 checked references that resolve
resolves10.1080/07388551.2019.1576025
Dietary fibers as emerging nutritional factors against diabetes: focus on the involvement of gut microbiota
resolves10.1016/S0140-6736(12)61350-6
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis
resolves10.1007/s11892-017-0844-9
Caveolin-1 in the Pathogenesis of Diabetic Nephropathy: Potential Therapeutic Target?
resolves10.1080/0886022X.2016.1227920
Renoprotective effect of<i>Bacopa monnieri via</i>inhibition of advanced glycation end products and oxidative stress in STZ-nicotinamide-induced diabetic nephropathy
resolves10.2337/diab.32.2.S64
The Stages in Diabetic Renal Disease: With Emphasis on the Stage of Incipient Diabetic Nephropathy
resolves10.1159/000323139
Proteinuria in Type 2 Diabetic Patients with Renal Impairment: The Changing Face of Diabetic Nephropathy
resolves10.1017/S0007114517001805
Dietary polyphenol intake and risk of type 2 diabetes in the Polish arm of the Health, Alcohol and Psychosocial factors in Eastern Europe (HAPIEE) study
resolves10.1016/j.bbrc.2003.08.105
Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses
resolves10.1159/000300388
Resveratrol Attenuates Renal Hypertrophy in Early-Stage Diabetes by Activating AMPK
resolves10.1007/s12011-007-0031-y
Pretreatment Effect of Resveratrol on Streptozotocin-Induced Diabetes in Rats
resolves10.1159/000089720
Resveratrol, a Polyphenolic Phytoalexin, Attenuates Diabetic Nephropathy in Rats
resolves10.1007/s00125-012-2747-2
Resveratrol prevents renal lipotoxicity and inhibits mesangial cell glucotoxicity in a manner dependent on the AMPK–SIRT1–PGC1α axis in db/db mice
resolves10.1017/S0007114511000316
Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients
resolves10.1016/j.nutres.2012.06.003
Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus
resolves10.1016/j.diabet.2018.05.010
Resveratrol reduces albuminuria in diabetic nephropathy: A randomized double-blind placebo-controlled clinical trial
resolves10.1002/dmrr.2841
Diabetic nephropathy in type 1 diabetes: a review of early natural history, pathogenesis, and diagnosis
resolves10.1016/j.vph.2013.01.001
Molecular mechanisms in the pathogenesis of diabetic nephropathy: An update
resolves10.1161/HYPERTENSIONAHA.109.149559
Effect of the Urotensin Receptor Antagonist Palosuran in Hypertensive Patients With Type 2 Diabetic Nephropathy
resolves10.1016/j.jcjd.2015.08.016
The Role of Renin Angiotensin Aldosterone System Genes in Diabetic Nephropathy
resolves10.1111/j.1440-1681.2009.05292.x
(Pro)renin receptor contributes to diabetic nephropathy by enhancing renal inflammation
resolves10.1038/sj.ki.5000011
Renin increases mesangial cell transforming growth factor-β1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms
resolves10.1093/ndt/gfq579
Aliskiren improves insulin resistance and ameliorates diabetic vascular complications in db/db mice
resolves10.1242/jcs.114.21.3905
TGF-β1-induced PAI-1 gene expression requires MEK activity and cell-to-substrate adhesion
resolves10.4161/oxim.3.2.11148
Advanced Glycation end Products, Oxidative Stress and Diabetic Nephropathy
resolves10.1210/er.2001-0039
Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes
resolves10.2337/db10-0386
Resveratrol Improves Oxidative Stress and Protects Against Diabetic Nephropathy Through Normalization of Mn-SOD Dysfunction in AMPK/SIRT1-Independent Pathway
resolves10.1016/j.mce.2014.12.010
Resveratrol prevents high glucose-induced epithelial–mesenchymal transition in renal tubular epithelial cells by inhibiting NADPH oxidase/ROS/ERK pathway
resolves10.1007/s00125-009-1458-9
Multiple levels of regulation determine the role of the receptor for AGE (RAGE) as common soil in inflammation, immune responses and diabetes mellitus and its complications
resolves10.2337/db16-0310
Advanced Glycation End Products Predict Loss of Renal Function and Correlate With Lesions of Diabetic Kidney Disease in American Indians With Type 2 Diabetes
resolves10.1056/NEJM199109193251202
Advanced Glycosylation End Products in Patients with Diabetic Nephropathy
resolves10.1097/01.ASN.0000077413.41276.17
Role of Advanced Glycation End Products in Diabetic Nephropathy
resolves10.5812/ijem.23542
Resveratrol-Dependent Down-Regulation of Receptor for Advanced Glycation End Products and Oxidative Stress in Kidney of Rats With Diabetes
resolves10.1016/j.taap.2017.11.025
Trans-resveratrol mitigates type 1 diabetes-induced oxidative DNA damage and accumulation of advanced glycation end products in glomeruli and tubules of rat kidneys
resolves10.1016/j.fsi.2019.06.006
The molecular mechanism of Nrf2-Keap1 signaling pathway in the antioxidant defense response induced by BaP in the scallop Chlamys farreri
resolves10.1016/j.bbadis.2011.03.008
Resveratrol protects diabetic kidney by attenuating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via Nrf2–Keap1 signaling
resolves10.1016/j.biocel.2012.01.001
High glucose induces renal mesangial cell proliferation and fibronectin expression through JNK/NF-κB/NADPH oxidase/ROS pathway, which is inhibited by resveratrol
resolves10.1016/j.taap.2011.09.028
Resveratrol protects against hyperglycemia-induced oxidative damage to mitochondria by activating SIRT1 in rat mesangial cells
resolves10.1016/j.diabres.2016.12.005
Resveratrol ameliorates hyperglycemia-induced renal tubular oxidative stress damage via modulating the SIRT1/FOXO3a pathway
resolves10.12659/MSM.911714
Resveratrol Reduces Oxidative Stress and Apoptosis in Podocytes via Sir2-Related Enzymes, Sirtuins1 (SIRT1)/Peroxisome Proliferator-Activated Receptor γ Co-Activator 1α (PGC-1α) Axis
resolves10.1002/jcp.27306
Resveratrol ameliorates podocyte damage in diabetic mice via SIRT1/PGC‐1α mediated attenuation of mitochondrial oxidative stress
resolves10.1016/j.biopha.2016.06.004
Effect of resveratrol and rosuvastatin on experimental diabetic nephropathy in rats
resolves10.1007/s11033-012-1780-z
The effect of resveratrol on FoxO1 expression in kidneys of diabetic nephropathy rats
resolves10.1080/13813455.2018.1437752
Concomitant administration of resveratrol and insulin protects against diabetes mellitus type-1-induced renal damage and impaired function via an antioxidant-mediated mechanism and up-regulation of Na<sup>+</sup>/K<sup>+</sup>-ATPase
resolves10.1016/j.prp.2016.02.001
Sirt1 is essential for resveratrol enhancement of hypoxia-induced autophagy in the type 2 diabetic nephropathy rat
resolves10.1038/srep45692
Resveratrol protects podocytes against apoptosis via stimulation of autophagy in a mouse model of diabetic nephropathy
resolves10.1007/s11033-014-3064-2
The effect of resveratrol on the expression of AdipoR1 in kidneys of diabetic nephropathy
resolves10.1186/s12967-016-0922-9
Resveratrol increases AdipoR1 and AdipoR2 expression in type 2 diabetic nephropathy
resolves10.1007/s00109-016-1451-y
Resveratrol inhibits renal interstitial fibrosis in diabetic nephropathy by regulating AMPK/NOX4/ROS pathway
resolves10.1371/journal.pone.0082336
Resveratrol Attenuates Diabetic Nephropathy via Modulating Angiogenesis
resolves10.1152/physrev.00030.2009
Regulation of Mammalian Autophagy in Physiology and Pathophysiology
resolves10.1371/journal.pone.0060546
Autophagy Attenuates Diabetic Glomerular Damage through Protection of Hyperglycemia-Induced Podocyte Injury
resolves10.1016/j.yexcr.2014.01.001
Autophagy inhibition induces podocyte apoptosis by activating the pro-apoptotic pathway of endoplasmic reticulum stress
resolves10.3892/ijmm.2013.1609
Enhancement in efferocytosis of oxidized low-density lipoprotein-induced apoptotic RAW264.7 cells through Sirt1-mediated autophagy
resolves10.1016/j.biopha.2014.12.021
Study of autophagy-related protein light chain 3 (LC3)-II expression levels in thyroid diseases
resolves10.1074/jbc.M110650200
Role of Sterol Regulatory Element-binding Protein 1 in Regulation of Renal Lipid Metabolism and Glomerulosclerosis in Diabetes Mellitus
resolves10.3389/fmed.2015.00052
Alteration of Fatty Acid Oxidation in Tubular Epithelial Cells: From Acute Kidney Injury to Renal Fibrogenesis
resolves10.1007/s11010-015-2576-y
Resveratrol prevents renal lipotoxicity in high-fat diet-treated mouse model through regulating PPAR-α pathway
resolves10.1590/S0004-27302009000200012
Protective roles of adiponectin in obesity-related fatty liver diseases: mechanisms and therapeutic implications
resolves10.1007/s10735-008-9198-6
Adiponectin stimulates phosphorylation of AMP-activated protein kinase α in renal glomeruli
resolves10.1007/s00018-015-2052-6
The endoplasmic reticulum: structure, function and response to cellular signaling
resolves10.2337/db12-0716
Endoplasmic Reticulum Stress Plays a Key Role in the Pathogenesis of Diabetic Peripheral Neuropathy
resolves10.2353/ajpath.2010.090386
Induction of Diabetes in Aged C57B6 Mice Results in Severe Nephropathy
resolves10.1016/j.bbrc.2008.04.031
Apoptosis induced by endoplasmic reticulum stress involved in diabetic kidney disease
resolves10.2337/db13-1279
Epidermal Growth Factor Receptor Inhibition Slows Progression of Diabetic Nephropathy in Association With a Decrease in Endoplasmic Reticulum Stress and an Increase in Autophagy
resolves10.1007/s00011-006-6190-z
Improvement of inflammatory responses associated with NF-κB pathway in kidneys from diabetic rats
resolves10.1113/jphysiol.2006.108324
AMPK and cell proliferation – AMPK as a therapeutic target for atherosclerosis and cancer
resolves10.1152/ajprenal.00278.2006
A role for AMP-activated protein kinase in diabetes-induced renal hypertrophy
resolves10.1074/jbc.M110.136796
AMP-activated Protein Kinase (AMPK) Negatively Regulates Nox4-dependent Activation of p53 and Epithelial Cell Apoptosis in Diabetes
resolves10.1016/j.jnutbio.2014.03.010
Increase in AMPK brought about by cocoa is renoprotective in experimental diabetes mellitus by reducing NOX4/TGFβ-1 signaling
resolves10.1053/j.ajkd.2004.09.020
Vascular endothelial growth factor gene expression is correlated with glomerular neovascularization in human diabetic nephropathy
resolves10.1046/j.1469-7580.2002.00066.x
Regulation of microvascular permeability by vascular endothelial growth factors*
The 7 references without a DOI — listed, not checked
no DOI — not checkedUS Renal Data System 2010 annual data report
no DOI — not checkedResveratrol prevention of diabetic nephropathy is associated with the suppression of renal inflammation and mesangial cell proliferation: possible roles of Akt/NF-κB pathway
no DOI — not checkedStructural involvement in type 1 and type 2 diabetic nephropathy
no DOI — not checkedResveratrol transcriptionally regulates miRNA-18a-5p expression ameliorating diabetic nephropathy via increasing autophagy
no DOI — not checkedProtective effect of resveratrol on kidney in rats with diabetic nephropathy and its effect on endoplasmic reticulum stress
no DOI — not checkedSirtuins and renal diseases: relationship with aging and diabetic nephropathy
no DOI — not checkedAdiponectin regulates albuminuria and podocyte function in mice
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-22 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1093/advances/nmaa075"><img src="https://citestamp.com/citestamped/10.1093/advances/nmaa075/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1093/advances/nmaa075)